Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Barth KS, Ball S, Adams RS, Nikitin R, Wooten NR, Qureshi ZP, Larson MJ.

J Contin Educ Health Prof. 2017 Spring;37(2):98-105. doi: 10.1097/CEH.0000000000000149.

2.

Targeting practitioners: A review of guidelines, training, and policy in pain management.

Barth KS, Guille C, McCauley J, Brady KT.

Drug Alcohol Depend. 2017 Apr 1;173 Suppl 1:S22-S30. doi: 10.1016/j.drugalcdep.2016.08.641. Review.

3.

Treatment of Prescription Opioid Use Disorder in Pregnant Women.

Guille C, Barth KS, Mateus J, McCauley JL, Brady KT.

Am J Psychiatry. 2017 Mar 1;174(3):208-214. doi: 10.1176/appi.ajp.2016.16060710. No abstract available.

4.

Dialectical behavior therapy as treatment for borderline personality disorder.

May JM, Richardi TM, Barth KS.

Ment Health Clin. 2016 Mar 8;6(2):62-67. doi: 10.9740/mhc.2016.03.62. eCollection 2016 Mar.

5.

Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients.

Madan A, Borckardt JJ, Balliet WE, Barth KS, Delustro LM, Malcolm RM, Koch D, Willner I, Baliga P, Reuben A.

Int J Psychiatry Med. 2015;49(4):279-95. doi: 10.1177/0091217415589304. Epub 2015 Jun 15.

PMID:
26078395
6.

Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.

Bentzley BS, Barth KS, Back SE, Aronson G, Book SW.

J Subst Abuse Treat. 2015 Sep;56:48-53. doi: 10.1016/j.jsat.2015.04.002. Epub 2015 Apr 7.

7.

Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.

Bentzley BS, Barth KS, Back SE, Book SW.

J Subst Abuse Treat. 2015 May;52:48-57. doi: 10.1016/j.jsat.2014.12.011. Epub 2014 Dec 30. Review.

8.

Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study.

Sahlem GL, Kalivas B, Fox JB, Lamb K, Roper A, Williams EN, Williams NR, Korte JE, Zuschlag ZD, El Sabbagh S, Guille C, Barth KS, Uhde TW, George MS, Short EB.

J Psychiatr Res. 2014 Dec;59:101-7. doi: 10.1016/j.jpsychires.2014.08.015. Epub 2014 Sep 3.

9.

Pain management perceptions among prescription opioid dependent individuals.

McCauley JL, Mercer MA, Barth KS, Brady KT, Back SE.

Drug Alcohol Depend. 2014 Sep 1;142:354-8. doi: 10.1016/j.drugalcdep.2014.06.024. Epub 2014 Jun 25.

10.

Laboratory-induced cue reactivity among individuals with prescription opioid dependence.

Back SE, Gros DF, McCauley JL, Flanagan JC, Cox E, Barth KS, Brady KT.

Addict Behav. 2014 Aug;39(8):1217-23. doi: 10.1016/j.addbeh.2014.04.007. Epub 2014 Apr 12.

11.

Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain.

Barth KS, Balliet W, Pelic CM, Madan A, Malcolm R, Adams D, Morgan K, Owczarski S, Borckardt JJ.

Pain Med. 2014 Aug;15(8):1359-64. doi: 10.1111/pme.12403. Epub 2014 Apr 9.

12.

Interprofessional collaborative care reduces excess service utilization among individuals with chronic pancreatitis.

Madan A, Borckardt JJ, Barth KS, Romagnuolo J, Morgan KA, Adams DB.

J Healthc Qual. 2013 Sep-Oct;35(5):41-6. doi: 10.1111/jhq.12025.

PMID:
24004038
13.

Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Barth KS, Maria MM, Lawson K, Shaftman S, Brady KT, Back SE.

Am J Addict. 2013 Sep-Oct;22(5):486-91. doi: 10.1111/j.1521-0391.2013.12038.x. Epub 2013 May 15.

14.

Chronic pain among liver transplant candidates.

Madan A, Barth KS, Balliet WE, Hernandez-Tejada MA, Borckardt JJ, Malcolm R, Willner I, Koch D, Reuben A.

Prog Transplant. 2012 Dec;22(4):379-84.

PMID:
23187056
15.

Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids.

Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.

J Addict Med. 2010 Sep;4(3):167-73. doi: 10.1097/ADM.0b013e3181c379ed.

PMID:
21769031
16.

Food cravings and the effects of left prefrontal repetitive transcranial magnetic stimulation using an improved sham condition.

Barth KS, Rydin-Gray S, Kose S, Borckardt JJ, O'Neil PM, Shaw D, Madan A, Budak A, George MS.

Front Psychiatry. 2011 Mar 14;2:9. doi: 10.3389/fpsyt.2011.00009. eCollection 2011.

17.

Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.

Snarr BS, Phan SV, Garner A, VandenBerg AM, Barth KS.

Ann Pharmacother. 2010 Apr;44(4):760-3. doi: 10.1345/aph.1M621. Epub 2010 Mar 9.

PMID:
20215494
18.

Disulfiram: an old therapeutic with new applications.

Barth KS, Malcolm RJ.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):5-12. Review.

PMID:
20201810
19.

The association between chronic pain and prescription drug abuse in Veterans.

Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT, Oslin DW.

Pain Med. 2009 Apr;10(3):531-6.

PMID:
19425211
20.

Characteristics and outcomes of patients discharged from the Opioid Renewal Clinic at the Philadelphia VA Medical Center.

Becker WC, Meghani SH, Barth KS, Wiedemer N, Gallagher RM.

Am J Addict. 2009 Mar-Apr;18(2):135-9. doi: 10.1080/10550490902772496.

PMID:
19283565

Supplemental Content

Loading ...
Support Center